ARG1 and neoplasm: Hydrogels loaded with norvaline and doxorubicin hydrochloride achieved high drug loading and controlled release of norvaline to block the ARG1 pathway, showing promising efficacy in primary tumor ablation and inhibition of tumor metastasis (Ren et al., 2021).